One Organic Chemist One Day: Iwona Wrona Receives Novartis Fellowship in Organic Chemistry for Women and Minorities

DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Saturday, 10 October 2015

Iwona Wrona Receives Novartis Fellowship in Organic Chemistry for Women and Minorities

Dr. Iwona Wrona Ph. D. 2009
iwona.wrona@cubist.com
Iwona joined the Panek group in 2004.

B.A. Chemistry 2002 College of the Holy Cross

https://www.linkedin.com/pub/iwona-wrona/6/b8b/745

Summary

Project Leader with seven years of pharmaceutical experience in pain and antibacterial therapeutic areas. Key member of a team that delivered an IND candidate and co-inventor of two development candidates that have progressed to pre-clinical studies. Highly motivated team leader who supervised, coached and developed a multidisciplinary team of scientists. Expertise in organic chemistry, medicinal chemistry, analog synthesis/design, experiment troubleshooting, hit to lead- triage, lead optimization and project leadership.

Experience

Scientist II

Cubist Pharmaceuticals

January 2012 – March 2015 (3 years 3 months)Lexington, MA

Project Leader, TRPA1
• Analyzed HTS data for validation and follow up, resulting in two novel hit to lead series
• Advanced one series to LO stage affording several compounds with promising efficacy in animal models
• Effectively managed team of up to 12 chemists (including external CRO FTEs) and line-managed two direct reports, resulting in high level of productivity and quality
• Worked across disciplines to identify key project issues and to define and implement chemistry plan
• Co-inventor of TRPA1 development candidate drug that has progressed into pre-clinical studies

(Open)1 honor or award
(Open)3 courses

Scientist I

Cubist Pharmaceuticals

February 2009 – December 2011 (2 years 11 months)Lexington, MA

Transient Receptor Potential Ankyrin 1 (TRPA1) Project
• Chemistry lead for TRPA1 program managing a team of up to 5 chemists
• Designed and synthesized molecules in collaboration with Hydra Biosciences, Inc. resulting in advancement of CB-625 into Phase I clinical trials
• Designer, contributor/executor of the pro-drug scale up campaign to improve solubility of the Xanthine series, resulting in two pre-development candidates
Thiopeptide Program
• Designed and synthesized semi-synthetic thiopetide analogs to improve solubility
• Identified multiple entry points for rapid SAR development

(Open)1 honor or award
(Open)2 courses

Senior Scientist

Schering-Plough Research Institute

May 2008 – January 2009 (9 months)Cambridge, MA

• Designed and synthesized small molecule inhibitors of mTOR kinase for treatment of cancer

Education

Boston University

Doctor of Philosophy (Ph.D.), Organic Chemistry

2002 – 2008

Adviser: Professor James S. Panek
Dissertation:
I. Total Synthesis and Biological Evaluation of Reblastatin, Autolytimycin and Related Structural Derivatives
II. Synthesis and Biological Evaluation of Stereochemical Analogs of Bistramide A

(Open)2 honors and awards

College of the Holy Cross

BA, Chemistry, Cum Laude

1998 – 2002

Ms. Sujata Bardhan (2004/2005 Novartis Fellow), Prof. John Porco, and Ms. Iwona Wrona (2005/2006 Novartis Fellow)

....

.

Iwona Wrona is a fourth year graduate student in James Panek’s laboratory. She graduated with a B.A. in chemistry (cum laude) from the College of the Holy Cross, Worcester, MA (2002), and she received her M.S. in Chemistry from Boston University (2004). Iwona is working on the total synthesis of reblastatin.
Her publications include:

Wrona, I. E.; Gabarda, A. E.; Evano, G.; Panek, J. S. “Total Synthesis of Reblastatin”, J . Am. Chem. Soc. 2005, 127, 15026.
Herrick, R. S.; Wrona, I.; McMicken, N.; Jones, G.; Ziegler, C.; Shaw, J. “Preparation and Characterization of Rhenium(I) Compounds with Amino Ester Derivatized Diimine Ligands. Investigations of Luminescence. Crystal Structures of Re(CO)3Cl(pyca-β-Ala-OEt) and Re(CO)3Cl(pyca-L-Asp(OMe)-OMe)”, J. Organometallic Chemistry 2004, 689,4848.
Herrick, R. S.; Ziegler, C. J.; Bohan, H.; Corey, M.; Eskander, M.; Giguere, J.;
McMicken, N.; Wrona, I. E. “Preparation and Characterization of Molybdenum andTungsten Compounds with Diazabutadiene Ligands Constructed from Amino Esters and Glyoxal. Crystal Structures of meso and C2-symmetric isomers of Mo(CO)4(dabasp(OMe)-OMe”, J. Organometallic Chemistry 2003, 687, 178.